Balance Control and Recovery in Diabetes Peripheral Neuropathy
Lisa Griffin · NCT06544876
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 50–99 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 60
- US sites recruiting
- 1
- Study start
- September 12, 2023
- Record last updated
- August 9, 2024
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
In this study the effects of diabetic peripheral neuropathy will be assessed on balance control, balance recovery, and muscle electrical activity in adults over 50 years.
Aim 1: Determine muscle activity and balance control during a sit-to-stand in adults age above 50 with and without diabetic peripheral neuropathy.
Aim 2: Assess local balance recovery and latency responses to lateral surface perturbation during quiet standing.
Being studied: sit-to-stand; stand to sit; standing perturbation; MRI of sciatic nerve
Conditions: Diabetic Peripheral Neuropathy; Diabetic Peripheral Neuropathy Type 2; Diabetic Peripheral Neuropathy Type 2 - Uncontrolled; Healthy Aging
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Type II diabetes with peripheral neuropathy
Exclusion Criteria
- Foot ulcer
- Partial amputation
- Have experience of Stroke
- Painful neuropathy
- Inability to stand or walk independently
Recruiting US locations
The University of Texas at Austin
Austin, TX 78712
Site contact: Mohsen Alighanbari, M.Sc. · 512-471-9228 · m.alighanbari@utexas.edu
Similar studies in Texas
All diabetes studies in Texas →- RecruitingHealthy volunteersPhase 1
Study of GS-4571 in Healthy Participants, Nondiabetic Obese Participants, and Nonobese Participants With Type 2 Diabetes Mellitus (T2DM)
Gilead Sciences
- Location
- San Antonio, TX + 2 other US sites
- Eligibility basics
- Ages 18–65
- RecruitingHealthy volunteersPhase 1
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD4248 in Healthy Participants and Participants With Chronic Kidney Disease and Type 2 Diabetes and to Assess Home Measurements of…
AstraZeneca
- Location
- San Antonio, TX + 3 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingHealthy volunteersPhase 1
Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME)
Ocugen
- Location
- Bellaire, TX + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1Overnight stay mentioned
MAD Study to Assess the Safety, Tolerability, PKs and Efficacy of YJ001 for Spray Use in Patients With DPNP
Zhejiang Hanmai Pharmaceutical Technology Co., Ltd.
- Location
- Fredericksburg, TX
- Eligibility basics
- Ages 18–80